Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Heart Failure VI: Adjunct Therapies

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.

Heart Failure VII: Nursing Interventions

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...

Heart Failure V: Medical Management

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...

Heart Failure II: Pathophysiology

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...

Pathophysiology of Heart Failure

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...

Mitral Regurgitation IV: Nursing Management

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Cardiac Amyloidosis: An Updated Review With Emphasis on Diagnosis and Future Directions.

Current problems in cardiology·2017

Same author

Cardiorespiratory Fitness and Health Outcomes: A Call to Standardize Fitness Categories.

Mayo Clinic proceedings·2017

Same author

Survival of the Fittest-Promoting Fitness Throughout the Life Span.

Mayo Clinic proceedings·2017

Same author

Four Years as Editor-in-Chief.

Progress in cardiovascular diseases·2017

Same author

Vitamin D Metabolism and the Implications for Atherosclerosis.

Advances in experimental medicine and biology·2017

Same author

Duration of Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

Current problems in cardiology·2017

Search research articles

Related Experiment Videos

Micronutrients in chronic heart failure.

Selim R Krim¹, Patrick Campbell, Carl J Lavie

¹Department of Cardiology, John Ochsner Heart and Vascular Institute, Ochsner Clinical School-The University of Queensland School of Medicine, Ochsner Clinic Foundation, 1514 Jefferson Highway, New Orleans, LA 70121, USA. Skrim@ochsner.org

Current Heart Failure Reports

|October 17, 2012

Summary

This summary is machine-generated.

Micronutrient deficiencies worsen heart failure (HF) outcomes. Supplementing key vitamins like D and B, plus CoQ10 and L-carnitine, may improve survival in HF patients with poor nutrition.

Related Experiment Videos

Area of Science:

Cardiology
Nutritional Science
Biochemistry

Background:

High mortality persists in heart failure (HF) despite optimal medical management.
Poor nutritional status and cachexia are linked to reduced survival in HF patients.
Micronutrient deficiencies may drive HF progression.

Purpose of the Study:

To review current evidence on micronutrients in HF pathophysiology and outcomes.
To highlight the roles of specific micronutrients in HF management.

Main Methods:

Systematic review of contemporary scientific literature.
Focus on well-researched micronutrients: vitamin D, vitamin B complex, coenzyme Q10, and L-carnitine.

Main Results:

Micronutrient status significantly impacts HF progression and patient survival.
Evidence suggests potential benefits of specific micronutrient interventions.

Conclusions:

Addressing micronutrient deficiencies is crucial for improving HF patient outcomes.
Further research into targeted micronutrient supplementation is warranted for HF management.